Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B InfectionMan‐Fung Yuen, Dickens Theodore, Seng Gee Lim et al.|New England Journal of Medicine|2022Cited by 264
Analysis of 307 cases with drug‐induced liver injury between 2010 and 2018 in JapanMitsuhiko Aiso, Naoya Sakamoto, Hajime Takikawa et al.|Hepatology Research|2018Cited by 61
Antithrombin III for portal vein thrombosis in patients with liver disease: A randomized, double‐blind, controlled trialHisashi Hidaka, Tomohiko Akahoshi, Shozo Hirota et al.|Hepatology Research|2017Cited by 57
Clinical characteristics of immunoglobulin IgG4-related sclerosing cholangitis: Comparison of cases with and without autoimmune pancreatitis in a large cohortItaru Naitoh, Satoshi Takai, Terumi Kamisawa et al.|Digestive and Liver Disease|2021Cited by 32
Safety and efficacy of dual therapy with daclatasvir and asunaprevir for older patients with chronic hepatitis CReona Morio, Kazuaki Chayama, Michio Imamura et al.|Journal of Gastroenterology|2016Cited by 20